US 9744169
Compounds for treatment of fibrosis diseases
granted A61KA61K31/444A61K31/4725
Quick answer
US patent 9744169 (Compounds for treatment of fibrosis diseases) held by Curegenix, Inc. expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Curegenix, Inc.
- Grant date
- Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/444, A61K31/4725, A61K31/497, A61K31/4985